The Little Blue Pill That Killed the Little Pink House

Author:

Olejarski Amanda M.1,Farley Kathryn Webb2

Affiliation:

1. Shippensburg University, PA, USA

2. Presidential Management Fellow, Washington, DC, USA

Abstract

Community and business interests are set in opposition, rather than in a harmonious balance, in the 2005 landmark U.S. Supreme Court decision in Kelo v. New London. The narrative of eminent domain, through the lens of Kelo, highlights these conflicting values. The case presents a local government that used its power of takings to attract Pfizer, the pharmaceutical conglomerate, to build a plant for production of the little blue pill, which symbolizes private interests in this case. The community’s dissension of taking an individual’s private property for use by another private entity centered on a pink house, which has come to be known as the symbol of eminent domain abuse. This narrative is explored through in-depth interviews with public administrators experienced with eminent domain, community grassroots organizers involved with the case, and relevant articles from the local newspaper. A key finding of the study surrounds similarities between the perspectives of those people involved in Kelo and administrators throughout the state of Connecticut, the birthplace of the case. Although a nation built on the notion of the right to hold private property, the case suggests that in an era of late capitalism, business is of utmost importance to the community regardless of citizens’ desires in the United States.

Publisher

SAGE Publications

Subject

Marketing,Public Administration,Sociology and Political Science

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Irrelevance of “Public Use” in State Eminent Domain Reforms;The American Review of Public Administration;2017-09-14

2. The Missing Piece: The Case for Administrative Law in the MSPA Curriculum;Administration & Society;2017-03-23

3. Property and Administration;Administration & Society;2013-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3